Companies: 10,795·Total market cap: $144.5T
Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc.

LTUSOTCFinancial Services● Active
$0.00
+$0.00(+0.00%)
Market Cap$98773
P/E Ratio
52W High$0.0111
52W Low$0.0025
Overview

Lotus Pharmaceuticals, Inc. (LTUS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LTUS · as of Jun 9, 2026

Key Statistics

EPS (TTM)$0.00ltus eps ttm · ltus earnings per shareEarnings history
PE Ratio (TTM)ltus pe ratio ttm · ltus price to earningsPE Ratio deep dive
Revenue (TTM)0.00ltus revenue ttm · ltus annual revenueFull revenue history
Dividend YieldNo Dividenddoes ltus pay dividends · ltus dividend yieldDividend history
Shares Outstanding2.69Bltus shares outstanding · ltus floatShares outstanding history
Next EarningsTBAltus earnings date · ltus next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
lotus pharmaceuticals, inc. revenue · ltus revenue 2025
FY 2025Net Income-$29031.00▼ 126.15% YoY
202320242025
lotus pharmaceuticals, inc. net income · ltus profit 2025
FY 2025EPS$0.00
202320242025
ltus eps · lotus pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$33768.00EPS: $0.00View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M-11.33%
YTD+20.00%
1Y-28.00%
5Y-93.57%

About Lotus Pharmaceuticals, Inc.

CEOZhong Yi Liu
IPO DateAug 9, 2005
Employees233
CountryUS

Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of …

what is lotus pharmaceuticals, inc. · ltus stock overview · lotus pharmaceuticals, inc. company profile · who is lotus pharmaceuticals, inc. ceo · ltus OTC · lotus pharmaceuticals, inc. headquarters · lotus pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Lotus Pharmaceuticals, Inc. (LTUS) is a Financial Services company in the Shell Companies industry, listed on OTC since Aug 9, 2005. As of the latest trading session, LTUS stock price is $0.00, with a market capitalization of $98,773. The stock has returned -28.00% over the past 12 months and +20.00% year-to-date.

In fiscal year 2025, Lotus Pharmaceuticals, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Lotus Pharmaceuticals, Inc. (LTUS) stock price is $0.00. The stock is traded on OTC under the ticker symbol LTUS. The 52-week range is $0.00 – $0.01.

LTUS stock priceLTUS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice